News
Voices of Hodgkin’s Blog
Voices of Hodgkin’s Blog

Significant Progression-Free Survival in Stage III/IV Classic Hodgkin Lymphoma

A Phase III trial has demonstrated that patients with advanced Stage III/IV classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

How Do I Find Survivorship Care?

As part of LLS’s series “How Do I?”, Dr. Samantha Siegel, Onco-PCP expert explains how to find survivorship care after cancer treatment.

I’m a ‘Syringe Half-Full’ Kinda Girl

Meet Sheilagh Foley, a Hodgkin’s survivor with a familiar tale to tell, and she does it so beautifully. Hodgkin’s International was mentioned as a resource, and we are thrilled to have the “shout out!”

Surgeon Q&A: Radiation Associated Heart Valve Disease with Dr. Douglas Johnston

While the treatment of various cancers using radiation therapy for conditions including Hodgkin’s disease is regarded as a “medical miracle”, patients are often unaware that radiation can negatively impact organs including the heart, the lungs and the esophagus. Specific to the heart, there is a strong association among radiation therapy and heart valve disease, coronary artery disorders, ascending aorta defects and pericardium issues.